Antidote
Latest round
- Seed
Last raised
- Jan 2026
Total raised
- $5M
Investors
- 3
About Antidote
Team 34 Limited, doing business as Antidote and based in the UK, provides an AI-driven legal billing compliance solution for law firms, focusing on automating guideline checks and correcting time entries in real-time, thereby enhancing billing efficiency and compliance. Founded in 2024, by Nicholas d'Adhemar and Matt Lyons, Team 34 Limited, doing business as Antidote, specializes in AI-powered legal billing solutions. The company is headquartered in London, UK. The firm has engaged in two deals to date, marking its initial steps in the legal tech industry, focusing on compliance issues in billing operations. Antidote offers an AI-powered legal billing compliance solution designed for law firms, focusing on automating guideline checks and correcting time entries in real-time. This core product aims to address the challenges of non-compliant billing practices which can lead to significant revenue loss due to write-offs and slow collections. By utilizing advanced AI technology, Antidote enables firms to streamline their billing processes, ensuring that invoices are compliant and sent to clients promptly. The solution is tailored for high-performing law firms across key markets, including the United States, Europe, and Australia, catering primarily to large firms with substantial billing volumes.Antidote generates revenue through a business-to-business model, primarily focusing on partnerships with law firms that utilize its compliance solution. The transaction structure typically involves subscription-based pricing, where firms pay for access to the platform based on their individual needs and the scale of their operations. As law firms implement Antidote's services, they experience benefits such as accelerated billing cycles and reduced write-offs, contributing to overall financial stability. The pricing plans are designed to accommodate varying sizes of law firms, allowing them to align the cost of the service with their specific billing needs. Antidote’s flagship offering, centered around AI-powered legal billing compliance, is strategically positioned to reclaim lost revenue and enhance client trust by ensuring accurate invoicing practices. Antidote is also exploring the launch of new product features aimed at further optimizing billing compliance processes, although specific release dates have not yet been announced. Additionally, expansion into new geographic markets, particularly in North America and Asia, is on the horizon, with plans to establish a presence there by late 2026.
Who invested in Antidote
3 investors across 1 round
See all investors in Antidote
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 8, 2026
Amount
$5M
Investors
Questions about Antidote
Who invested in Antidote?
Antidote has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Antidote raised?
Antidote has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Antidote last raise money?
Antidote's most recent round on record is a Seed, in Jan 2026.
What does Antidote do?
Team 34 Limited, doing business as Antidote and based in the UK, provides an AI-driven legal billing compliance solution for law firms, focusing on automating guideline checks and correcting time entries in real-time, thereby enhancing billing efficiency and compliance.
Where is Antidote headquartered?
Antidote is headquartered in London, UK.
Which VCs invest in companies like Antidote?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Balderton Capital and Sofinnova Partners back software companies at Antidote's stage. Their profiles are linked below.
VCs backing software startups at Seed
Raising like Antidote? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.